Association between human papillomavirus vaccine status and other cervical cancer risk factors

Vaccine

Volumn 32, Issue 34, 2014, Pages 4310-4316

  Bowyer, Harriet L ^a   Dodd, Rachael H ^a   Marlow, Laura A V ^a   Waller, Jo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adolescent; Cancer risk; Cervical cancer; HPV; Immunisation; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; BLACK PERSON; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CAUCASIAN; COHORT ANALYSIS; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; HIGH SCHOOL; HUMAN; NORMAL HUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SMOKING; SOCIAL STATUS; UNITED KINGDOM; UTERINE CERVIX CANCER; VACCINATION; ATTITUDE TO HEALTH; BEHAVIOR; ETHNIC GROUP; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; ETHNIC GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; LONDON; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RISK FACTORS; SEXUAL BEHAVIOR; SMOKING; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84903819876     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.06.011     Document Type: Article

References (53)

1. Department of Health. Annual HPV vaccine uptake in England, 2010/2011. [accessed 8.01.12]. http://media.dh.gov.uk/network/211/files/2012/03/120319_HPV_UptakeReport2010-11-revised_acc.pdf.
2. Health and Social Care Information Centre Website. Cervical Screening Programme - England, 2012-2013. [accessed 7.11.13]. https://catalogue.ic.nhs.uk/publications/screening/cervical/cerv-scre-prog-eng-2012-13/cerv-scre-prog-eng-2012-13-rep.pdf.
3. Cancer Research UK Website. Cervical cancer statistics. [accessed 28.08.13]. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/cervix/.
4. Cuzick J., Castanon A., Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer 2010, 102(March (5)):933-939. 10.1038/sj.bjc.6605528.
5. Sasieni P., Castanon A., Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009, 339:b2968. 10.1136/bmj.b2968.
6. Moser K., Patnick J., Beral V. Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. BMJ 2009, 338:b2025. 10.1136/bmj.b2025.
7. Baker D., Middleton E. Cervical screening and health inequality in England in the 1990. J Epidemiol Commun Health 2003, 57:417-423.
8. Webb R., Richardson J., Pickles A. A population-based study of primary care predictors of non-attendance for cervical screening. J Med Screen 2004, 11(September (3)):135-140. 10.1258/0969141041732166.
9. Sutton S., Rutherford C. Sociodemographic and attitudinal correlates of cervical screening uptake in a national sample of women in Britain. Soc Sci Med 2005, 61(11):2460-2465. 10.1016/j.socscimed.2005.07.017.
10. Kjaer S., Chackerian B., van den Brule A.J.C., Svare E.I., Paull G., Walbomers J.M.M., et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001, 10:101-106.
11. Fonseca-Moutinho J.A. Smoking and cervical cancer. ISRN Obstet Gynecol 2011, 2011:847684. 10.5402/2011/847684.
12. Deacon J., Evans C.D., Yule R., Desai M., Binns W., Taylor C., et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000, 88(11):1565-1572. 10.1054/bjoc.2000.1523.
13. Green J., Berrington de Gonzalez A., Sweetland S., Beral V., Chilvers C., Crossley B., et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003, 89(December (11)):2078-2086. 10.1038/sj.bjc.6601296.
14. Hiscock R., Bauld L., Amos A., Fidler J.A., Munafò M. Socioeconomic status and smoking: a review. Ann N Y Acad Sci 2012, 1248(1):107-123. 10.1111/j. 1749-6632.2011.06202.x.
15. Tyas S.L., Pederson L.L. Psychosocial factors related to adolescent smoking: a critical review of the literature. Tob Control 1998, 7(4 (December 1)):409-420. 10.1136/tc.7.4.409.
16. Fenton K.A., Mercer C.H., McManus S., Erens B., Wellings K., Macdowall W., et al. Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey. Lancet 2005, 365(9466):1246-1255. 10.1016/S0140-6736(05)74813-3.
17. Wellings K., Nanchahal K., Macdowall W., McManus S., Erens B., Mercer C.H., et al. Sexual behaviour in Britain: early heterosexual experience. Lancet 2001, 358(9296):1843-1850. 10.1016/s0140-6736(01)06885-4.
18. Mercer C.H., Tanton C., Prah P., Erens B., Sonnenberg P., Clifton S., et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013, 382(9907):1781-1794. 10.1016/S0140-6736(13)62035-8.
19. Brabin L., Roberts S.A., Stretch R., Baxter D., Chambers G., Kitchener H., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008, 336(May (7652)):1056-1058. 10.1136/bmj.39541.534109.BE.
20. Perkins R.B., Pierre-Joseph N., Marquez C., Iloka S., Clark J.A. Parents' opinions of mandatory human papillomavirus vaccination: does ethnicity matter?. Womens Health Issues 2010, 20(November-December (6)):420-426. 10.1016/j.whi.2010.07.001.
21. Fisher H., Trotter C.L., Audrey S., Macdonald-Wallis K., Hickman M. Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis. Int J Epidemiol 2013, (April). 10.1093/ije/dyt049.
22. Desai S., Soldan K., White J., Sheridan A., Gill O.N. Human papillomavirus vaccine coverage. Lancet 2010, 376:328-329.
23. Roberts S.A., Brabin L., Stretch R., Baxter D., Elton P., Kitchener H., et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011, 139(March (3)):400-405. 10.1017/S095026881000066X.
24. Fisher H., Audrey S., Mytton J.A., Hickman M., Trotter C. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. J Public Health 2013 Apr 25, http://dx.doi.org/10.1093/pubmed/fdt042. 10.1093/pubmed/fdt042.
25. Hughes A., Mesher D., White J., Soldan K. Coverage of the English National human papillomavirus (HPV) Immunisation Programme among 12 to 17 year old females by area-level deprivation score, England, 2008 to 2011. Euro Surveill 2014, 19(2):1-6.
26. Mather T., McCaffery K., Juraskova I. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour?. Vaccine 2012, 30(May (21)):3196-3201. 10.1016/j.vaccine.2012.02.081.
27. Kuitto K., Pickel S., Neumann H., Jahn D., Metelmann H.-R. Attitudinal and socio-structural determinants of cervical cancer screening and HPV vaccination uptake: a quantitative multivariate analysis. J Public Health 2010, 18(2):179-188. 10.1007/s10389-009-0308-z.
28. Paul-Ebhohimhen V., Huc S., Tissington H., Oates K., Start C. HPV vaccination: vaccine acceptance, side effects and screening intentions. Community Pract. 2010, 83(6):30-33.
29. Beer H., Hibbitts S., Brophy S., Rahman M.A., Waller J., Paranjothy S. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?. Vaccine 2014, 32(April (16)):1828-1833. 10.1016/j.vaccine.2014.01.087.
30. Department of Health Annual HPV vaccine uptake in England: 2008/2009 2010, [accessed 8.11.13]. http://webarchive.nationalarchives.gov.uk/20100305101945/http%3A/www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111676.pdf.
31. Gov.UK Website (2013). Apply for free school meals. [accessed 8.11.13]. https://www.gov.uk/apply-free-school-meals.
32. The Poverty Site. UK: concentrations of poor children. [accessed 24.06.13]. http://www.poverty.org.uk/19/index.shtml.
33. The Telegraph. 2010 KS4 school league tables. [accessed 27.07.12]. http://schools.tmg.daltonfirth.co.uk/results/ks4/2010/by/REGCODE.LEA.
34. Bowyer H.L., Marlow L.A., Hibbitts S., Pollock K.G., Waller J. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England. Vaccine 2013, 31(February (7)):1051-1056. 10.1016/j.vaccine.2012.12.038.
35. Boyce W., Torsheim T., Currie C., Zambon A. The family affluence scale as a measure of national wealth: validation of an adolescent self-report measure. Soc Indic Res 2006, 78(3):473-487. 10.1007/s11205-005-1607-6.
36. Sheeran P., Orbell S. Using implementation intentions to increase attendance for cervical cancer screening. Health Psychol 2000, 19(May (3)):283-289. 10.1037/0278-6133.19.3.283.
37. IBM. SPSS Statistics for Windows (version 20.0) [Computer Program] IBM Corp. Armonk, NY.
38. Forster A.S., Marlow L.A., Stephenson J., Wardle J., Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012, 30(July (33)):4939-4944. 10.1016/j.vaccine.2012.05.053.
39. Bednarczyk R.A., Davis R., Ault K., Orenstein W., Omer S.B. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 2012, 130(November (5)):798-805. 10.1542/peds. 2012-1516.
40. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99(June (6)):1137-1142. 10.2105/AJPH.2008.147876.
41. Lefevere E., Hens N., Theeten H., Van den Bosch K., Beutels P., De Smet F., et al. Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine 2011, 29(October (46)):8390-8396. 10.1016/j.vaccine.2011.08.039.
42. Spencer Nee Pilkington A.M., Brabin L., Verma A., Roberts S.A. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England. Eur J Cancer 2013, 49(April (6)):1264-1272. 10.1016/j.ejca.2012.12.001.
43. Steens A., Wielders C.C., Bogaards J.A., Boshuizen H.C., de Greeff S.C., de Melker H.E. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: implications for future impact on prevention. Int J Cancer 2013, 132(February (4)):932-943. 10.1002/ijc.27671.
44. Chen H.Y., Kessler C.L., Mori N., Chauhan S.P. Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened. J Womens Health 2012, 21(November (11)):1132-1138. 10.1089/jwh.2011.3418.
45. National Cancer Intelligence Network. Cancer incidence and survival by major ethnic group, England, 2002-2006. [accessed 8.11.13]. http://publications.cancerresearchuk.org/downloads/product/CS_REPORT_INCSURV_ETHNIC.pdf.
46. Marlow L.A., Wardle J., Forster A.S., Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health 2009, 63(December (12)):1010-1015. 10.1136/jech.2008.085886.
47. Casillas A., Singhal R., Tsui J., Glenn B.A., Bastani R., Mangione C.M. The impact of social communication on perceived HPV vaccine effectiveness in a low-income, minority population. Ethn Dis 2011, 21:495-501.
48. Javanbakht M., Stahlman S., Walker S., Gottlieb S., Markowitz L., Liddon N., et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine 2012, 30(June (30)):4511-4516. 10.1016/j.vaccine.2012.04.062.
49. Bynum S.A., Brandt H.M., Sharpe P.A., Williams M.S., Kerr J.C. Working to close the gap: identifying predictors of HPV vaccine uptake among young African American women. J Health Care Poor Underserved 2011, 22(May (2)):549-561. 10.1353/hpu.2011.0060.
50. Department of Health Change in schedule from three to two doses in the HPV vaccination programme 2014, [accessed 16.05.14]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/310958/HPV_Joint_Letter_14_May.pdf.
51. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for completion of a 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009, 84(10):864-870. 10.1016/S0025-6196(11)60503-X.
52. Rolnick S.J., Parker E.D., Nordin J.D., Hedblom B.D., Wei F., Kerby T., et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?. Vaccine 2013, 31(37):3928-3935. 10.1016/j.vaccine.2013.06.041.
53. Stupiansky N.W., Zimet G.D., Cummings T., Fortenberry J.D., Shew M. Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. J Adolesc Health 2012, 50(January (1)):103-105. 10.1016/j.jadohealth.2011.04.010.